Dirui Medical: Announcement on the expiration of the implementation period of the plan for shareholders holding more than 5% of the shares to reduce their shareholdings
Securities code: 300396 Securities abbreviation: Dirui Medical Announcement number: 2025-039
Dirui Medical Technology Co., Ltd.
Announcement on the expiration of the implementation period of the share reduction plan for shareholders holding more than 5% of the shares
Guangdong Hengjian International Investment Co., Ltd., a shareholder holding more than 5% of the shares, guarantees that the information provided to the company is true, accurate and complete, and contains no false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the content of the announcement is consistent with the information provided by the information disclosure obligor.
Dirui Medical Technology Co., Ltd. (hereinafter referred to as the "Company") disclosed the "Pre-Disclosure Announcement on the Reduction of Shareholdings by Shareholders Holding More than 5% of the Shares" (Announcement Number: 2025-020) on May 8, 2025. For details, please refer to the announcement disclosed by cninfo.com.
The company recently received a notice from Guangdong Hengjian International Investment Co., Ltd. (hereinafter referred to as "Hengjian International"), a shareholder holding more than 5% of the shares. As of now, the implementation period of Hengjian International's shareholding reduction plan has expired, and Hengjian International has not reduced its shareholding in the company during the period of this shareholding reduction plan. In accordance with relevant regulations such as "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 18 - Reduction of Shareholdings by Shareholders, Directors and Senior Management", the specific situation is hereby announced as follows:
1. Shareholding reduction by shareholders
As of the disclosure date of this announcement, the implementation period of Hengjian International's shareholding reduction plan has expired, and the company's shares held by Hengjian International have not been reduced during the period of this shareholding reduction plan. Hengjian International holds 33,123,600 shares of the company, accounting for 12.15% of the company's current total share capital.
2. Other related instructions
Hengjian International’s shareholding reduction plan complies with the provisions of laws, regulations and normative documents such as the Company Law of the People’s Republic of China, the Securities Law of the People’s Republic of China, the Measures for the Administration of Acquisitions of Listed Companies, the Shenzhen Stock Exchange’s GEM Stock Listing Rules, the Interim Measures for the Management of Share Reductions by Shareholders of Listed Companies, the Shenzhen Stock Exchange’s Self-Discipline Supervision Guidelines for Listed Companies No. 18 - Reduction of Shares by Shareholders, Directors and Senior Management.
The above-mentioned shareholders’ reduction in the company’s shares has been pre-disclosed in accordance with relevant regulations. This reduction is in line with the disclosed reduction plan. The company’s shares were not reduced during this reduction plan, and there were no violations. As of now, the implementation period of this shareholding reduction plan has expired.
3. Documents for reference
"Letter on the Expiration of the Implementation Period of the Plan to Reduce Dirui Medical Shares" issued by Hengjian International.
Announcement is hereby made.
Board of Directors of Dirui Medical Technology Co., Ltd.
September 1, 2025